Safety and Immunogenicity Report from the Com-COV Study â a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine by Xinxue Liu, Robert H. Shaw, Arabella SV Stuart, Melanie Greenland, Tanya Dinesh, Samuel Provstgaard-Morys, Elizabeth Clutterbuck, Maheshi N. Ramasamy, Parvinder K. Aley, Yama Farooq Mujadidi, Fei Long, Emma Plested, Hannah Robinson, Nisha Singh, Laura L. Walker, Rachel White, Nick Andrews, J. Claire Cameron, Andrea M. Collins, Daniela M. Ferreira, Helen C. Hill, Christopher A. Green, Bassam Hallis, Paul T. Heath, Saul N. Faust, Adam Finn, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Mary E. Ramsay, Robert C. Read, David P. J. Turner, Paul J. Turner, Jonathan S. Nguyen-Van-Tam, Matthew D. Snape, Com-COV Study Group :: SSRN | Zootzle
